Since our results had indicated that PODX could elevate the soluble β-cat level/β-cat signaling through p38 MAPK in GBM cells, we next examined effects of PODX on the level of inactivating phosphorylation of GSK-3β at serine 189 in GBM cells. The gene discussed is CAT; the disease is glioblastoma.